DRKS00028535CompletedNot Applicable
Clinical investigation to evaluate safety and effectiveness of Geistlich TauroSept® used as adjunctive treatment in cancer patients with colonized or infected catheters
Centro di Riferimento Oncologico di Avioano (CRO)0 sites25 target enrollmentStarted: March 21, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 25
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Implanted VAD
- •- Clinical symptoms of fever and/or chills and blood tests compatible with catheter-colonization or with uncomplicated CRBSI (increased PCT, positive blood cultures from port/and/or peripheral vein)
Exclusion Criteria
- •- Not provided informed consent to use clinical data for study purposes
- •- Lack of documentation of required data in the medical records
- •- Patients with fungal or port-pocket infections
- •- Patients with VAD removed due to clinical instability
Investigators
Similar Trials
Completed
Not Applicable
Clinical research to evaluation the safety and efficacy of volume-reduced washed platelets in children with cancer.children with cancer.JPRN-UMIN000031481Shinshu University50
Active, not recruiting
Phase 1
Clinical investigation evaluating safety and efficacy of selective intra-arterial 166Holmium radiation therapy in combination with atezolizumab and bevacizumab for non resectable Hepatocellular carcinoma (HOLMBRAVE)on resectable Hepatocellular carcinoma (HCC)MedDRA version: 21.0Level: LLTClassification code: 10019828Term: Hepatocellular carcinoma non-resectable Class: 10029104CTIS2024-511538-11-00Institut Gustave Roussy40
Recruiting
Not Applicable
Clinical study to evaluate the effects and safety of Panax Ginseng Mayer extract and red ginseng to body temperatureKCT0003126Kyung Hee University Hospital180
Completed
Phase 2
Effect of Chawayan Shakti Powder(An Ayurvedic polyherbal combination) in improving physical health and immunity.CTRI/2022/10/046368KAG Industries, Nahan H.P35
Completed
Phase 3
A clinical Trial in patients with Vernal Keratoconjunctivitis. Clinical trial is to study efficacy, safety and tolerability of Tacrolimus Ophthalmic Suspension in comparison to Cyclosporine eye drops (reference product).CTRI/2010/091/001456Ajanta Pharma Ltd200